Apimeds Pharmaceuticals U... (APUS)
NYSE: APUS
· Real-Time Price · USD
1.84
0.09 (5.14%)
At close: Aug 19, 2025, 3:59 PM
1.88
2.17%
Pre-market: Aug 20, 2025, 05:00 AM EDT
Apimeds Pharmaceuticals US Inc Revenue
Apimeds Pharmaceuticals US Inc reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Apimeds Pharmaceuticals US Inc generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
2
Market Cap
21.3M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | n/a |
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |